Denosumab Plus Enzalutamide, Abiraterone and Prednisone Compared to Denosumab Plus Enzalutamide Alone for Men With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastases

NCT02758132 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Low accruals

Conditions

Prostate Cancer

Interventions

BIOLOGICAL: Denosumab
DRUG: Enzalutamide
DRUG: Abiraterone
DRUG: Prednisone

Sponsor

University of Hawaii